Mates Sharon
SEC insider (Form 3/4/5 filer). CIK 0001585699. Director at Seaport Therapeutics, Inc. (SPTX) and 2 other issuers. 25 reported Form 4/5 transactions since Sep 2024; latest on Apr 30, 2026. Located in HAYWARD, CA.
Companies Mates Sharon has filed insider reports for
- Seaport Therapeutics, Inc. (SPTX): Director
- Benitec Biopharma Inc. (BNTC): Director
- Intra-Cellular Therapies, Inc. (ITCI): Director, Officer, Chairman and CEO
Mates Sharon
CIK: 0001585699
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Apr 30, 2026SPTX
Seaport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
49K shares- - Jan 22, 2026BNTC
Benitec Biopharma Inc.
AwardDirectOptions (right to buy)
31.5K shares- - Dec 1, 2025BNTC
Benitec Biopharma Inc.
AwardDirectOptions (right to buy)
3.5K shares- - Nov 5, 2025BNTC
Benitec Biopharma Inc.
AwardDirectOptions (right to buy)
28.5K shares- - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
DispositionDirect945.2K shares at avg. $132.00$124.8M - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
AwardDirectPerformance Stock Units
40.7K shares- - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
DispositionIndirect190K shares at avg. $132.00$25.1M - Apr 2, 2025ITCI
Intra-Cellular Therapies, Inc.
AwardDirectPerformance Stock Units
35K shares- - Mar 26, 2025ITCI
Intra-Cellular Therapies, Inc.
GiftIndirect190K shares- - Mar 26, 2025ITCI
Intra-Cellular Therapies, Inc.
GiftDirect190K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 30, 2026 |  SPTX Seaport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 49,033 | - | - | Direct |
| Jan 22, 2026 |  BNTC Benitec Biopharma Inc. | Award Options (right to buy) | 31,500 | - | - | Direct |
| Dec 1, 2025 | BNTC Benitec Biopharma Inc. | Award Options (right to buy) | 3,500 | - | - | Direct |
| Nov 5, 2025 | BNTC Benitec Biopharma Inc. | Award Options (right to buy) | 28,517 | - | - | Direct |
| Apr 2, 2025 |  ITCI Intra-Cellular Therapies, Inc. | Disposition | 945,235 | $132.00 | $124,771,020 | Direct |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | Award Performance Stock Units | 40,712 | - | - | Direct |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | Disposition | 190,000 | $132.00 | $25,080,000 | Indirect |
| Apr 2, 2025 | ITCI Intra-Cellular Therapies, Inc. | Award Performance Stock Units | 34,970 | - | - | Direct |
| Mar 26, 2025 | ITCI Intra-Cellular Therapies, Inc. | Gift | 190,000 | - | - | Indirect |
| Mar 26, 2025 | ITCI Intra-Cellular Therapies, Inc. | Gift | 190,000 | - | - | Direct |
1-10 of 25 transactions